The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Quantification of Non-Transferrin-Bound Iron in the Presence of Unsaturated Transferrin
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A non-transferrin-bound serum iron in idiopathic hemochromatosis
Batey, R. G., Fong, P. L. C., Shamir, S., & Sherlock, S. (1980) · Digestive Diseases and Sciences · doi:10.1007/bf01308057 · Cited by 162
Cited by
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Non-transferrin bound iron: a key role in iron overload and iron toxicity
Brissot, P., Ropert, M., Le Lan, C., & Loréal, O. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.014 · Cited by 654
Self-citationHepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis
Yu, Y., Jiang, L., Wang, H., Shen, Z., Cheng, Q., Zhang, P., Wang, J., Wu, Q., Fang, X., Duan, L., et al. (2020) · Blood · doi:10.1182/blood.2019002907 · Cited by 601
Labile plasma iron in iron overload: redox activity and susceptibility to chelation
Esposito, B. P., Breuer, W., Sirankapracha, P., Pootrakul, P., Hershko, C., & Cabantchik, Z. I. (2003) · Blood · doi:10.1182/blood-2003-03-0807 · Cited by 475
Huang, X. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.023 · Cited by 444
The Role of Iron in Diabetes and Its Complications
Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423
“In fact, non-transferrin bound iron (NTBI) may be present in the serum even when transferrin is not fully saturated (62; 100).”
BackgroundLabile iron in cells and body fluids: Physiology, pathology, and pharmacology
Cabantchik, Z. I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00045 · Cited by 306
LPI-labile plasma iron in iron overload
CABANTCHIK, Z., BREUER, W., ZANNINELLI, G., & CIANCIULLI, P. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.10.003 · Cited by 293
Walter, P. B., Fung, E. B., Killilea, D. W., Jiang, Q., Hudes, M., Madden, J., Porter, J., Evans, P., Vichinsky, E., & Harmatz, P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06277.x · Cited by 288
Self-citationFleming, R. E., Migas, M. C., Holden, C. C., Waheed, A., Britton, R. S., Tomatsu, S., Bacon, B. R., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040548097 · Cited by 273
The importance of non-transferrin bound iron in disorders of iron metabolism
Breuer, W., Hershko, C., & Cabantchik, Z. I. (2000) · Transfusion Science · doi:10.1016/s0955-3886(00)00087-4 · Cited by 270
Jenkitkasemwong, S., Wang, C.-Y., Coffey, R., Zhang, W., Chan, A., Biel, T., Kim, J.-S., Hojyo, S., Fukada, T., & Knutson, M. D. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.002 · Cited by 245
“Plasma NTBI was measured by using a colorimetric method (Gosriwatana et al., 1999).”
Redox active plasma iron in C282Y/C282Y hemochromatosis
Le Lan, C., Loréal, O., Cohen, T., Ropert, M., Glickstein, H., Lainé, F., Pouchard, M., Deugnier, Y., Le Treut, A., Breuer, W., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3468 · Cited by 151
Self-citationCommon Presence of Non–Transferrin-Bound Iron Among Patients With Type 2 Diabetes
Lee, D.-H., Liu, D. Y., Jacobs, D. R., Shin, H.-R., Song, K., Lee, I.-K., Kim, B., & Hider, R. C. (2006) · Diabetes Care · doi:10.2337/dc05-2471 · Cited by 128
Self-citationJacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.03.008 · Cited by 101
Self-citationHepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia
Michels, K. R., Zhang, Z., Bettina, A. M., Cagnina, R. E., Stefanova, D., Burdick, M. D., Vaulont, S., Nemeth, E., Ganz, T., & Mehrad, B. (2017) · JCI Insight · doi:10.1172/jci.insight.92002 · Cited by 93
Walter, P. B., Macklin, E. A., Porter, J., Evans, P., Kwiatkowski, J. L., Neufeld, E. J., Coates, T., Giardina, P. J., Vichinsky, E., Olivieri, N., et al. (2008) · Haematologica · doi:10.3324/haematol.11755 · Cited by 87
“the short half-life of deferoxamine in the body after stopping an infusion results in a prolonged period each day when non-transferrin bound iron (NTBI) can be detected at elevated levels in the circulation.(6,7) NTBI has been suggested to be toxic to the heart and other iron-susceptible tissues.”
BackgroundSelf-citationNon‐Transferrin‐Bound Iron in Alcohol Abusers
de Feo, T. M., Fargion, S., Duca, L., Cesana, B. M., Boncinelli, L., Lozza, P., Cappellini, M. D., & Fiorelli, G. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02152.x · Cited by 48
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects
Zheng, H., Huang, X., Zhang, Q., & Katz, S. D. (2006) · Kidney International · doi:10.1038/sj.ki.5000046 · Cited by 44
Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes: Recent Developments
Leitch, H. A. (2011) · Drugs · doi:10.2165/11585280-000000000-00000 · Cited by 17
Metadata
- Authors
- Gosriwatana, I., Loreal, O., Lu, S., Brissot, P., Porter, J., & Hider, R. C.
- Venue
- Analytical Biochemistry
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 273
- Issue
- 2
- Pages
- 212-220
- ISSN
- 0003-2697 (ISSN-L)
- OpenAlex
- W1976659843
- Cited by
- 168
- References
- 1
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.